NCT04999761 2024-09-25AB122 Platform StudyTaiho Pharmaceutical Co., Ltd.Phase 1 Recruiting917 enrolled
NCT04480190 2022-04-20Neoadjuvant Therapy in Biliary AdenocarcinomaUniversity of CincinnatiPhase 1 Withdrawn